Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a new date and a new 'Study Status Contacts/Locations' section (as of 2025-10-03), and removed an older date (2025-09-08).
    Difference
    0.9%
    Check dated 2025-10-13T05:40:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    9%
    Check dated 2025-10-06T04:23:54.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows the new version label v3.1.0, replacing the old v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-28T23:48:12.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2 on 2025-09-08, adding a new 'Study Status Contacts/Locations' entry (dated 2025-09-05, with 59 items) and removing the 'Back to Top' element.
    Difference
    1%
    Check dated 2025-09-14T09:59:12.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.5%
    Check dated 2025-09-07T07:58:24.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and country listings.
    Difference
    49%
    Check dated 2025-08-31T01:06:50.000Z thumbnail image

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.